-
2025/06/17 (Delayed) Notice Regarding Partial Correction of Consolidated Financial Results for the Fiscal Year Ended March 31, 2025 (Under Japanese GAAP)
(67KB)
-
2025/06/16 Notice of New Capital Alliance with LINUS BIOTECHNOLOGY, INC. (U.S.A.)
(84KB)
読む Notice of New Capital Alliance with LINUS BIOTECHNOLOGY, INC. (U.S.A.)
-
2025/06/09 Notice of the 53rd Ordinary General Meeting of Shareholders
(468KB)
読む Notice of the 53rd Ordinary General Meeting of Shareholders
-
2025/05/22 Financial Review year ended Mar. 31, 2025 Presentation.
(1,929KB)
-
2025/05/19 Notice Concerning Revision of the Medium-Term Management Plan (FY 2024 to FY 2026)
(89KB)
読む Notice Concerning Revision of the Medium-Term Management Plan (FY 2024 to FY 2026)
IR events
-
May 22, 2025
Presentation for Annalist, Financial results for FY ended March 31, 2025
-
Consolidated Financial Results for the Fiscal Year Ended March 31, 2025(Under Japanese GAAP) (164KB)
-
Notice of Difference between Earnings Forecast and Actual Results for the Fiscal Year Ended March 31, 2025 (90KB)
-
FY2024 Supplementary materials for Financial Results_20250514 (2,664KB)
-
Financial Review year ended Mar. 31, 2025 Presentation (1,929KB)
-
Consolidated Financial Results for the Six Months Ended September 30, 2024(Under Japanese GAAP) (51KB)
-
Announcement on Consolidated Financial Forecast Revision for the year ending Mar.31,2025 (97KB)
-
Notice regarding Stock Split and Revision of Dividend Forecast 20241114 (82KB)
-
FY ending Mar. 31, 2025, Supplementary materials for interim financial results (2,866KB)